Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement

Paxton Loke; Kuang Chih Hsiao; Adriana Chebar Lozinsky; Sarah E. Ashley; Melanie Lloyd; Sigrid Pitkin; Christine Jean Axelrad; Kaushala S. Jayawardana; Dean Tey; Ee Lyn Su; Marnie Robinson; Agnes S.Y. Leung; Audrey Dunn Galvin; Mimi L.K. Tang

doi:10.1111/cea.14137

Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement

Paxton Loke
, Kuang Chih Hsiao
, Adriana Chebar Lozinsky
, Sarah E. Ashley
, Melanie Lloyd
, Sigrid Pitkin
, Christine Jean Axelrad
, Kaushala S. Jayawardana
, Dean Tey
, Ee Lyn Su
, Marnie Robinson
, Agnes S.Y. Leung
, Audrey Dunn Galvin
, Mimi L.K. Tang

School of Applied Psychology

Murdoch Children's Research Institute
University of Melbourne
Monash Children’s Hospital
Royal Children's Hospital Melbourne
Auckland District Health Board
The University of Auckland
Prince of Wales Hospital Hong Kong

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	806-811
Number of pages	6
Journal	Clinical and Experimental Allergy
Volume	52
Issue number	6
DOIs	https://doi.org/10.1111/cea.14137
Publication status	Published - Jun 2022

Keywords

health-related quality of life
oral immunotherapy
Peanut allergy
probiotic and peanut oral immunotherapy
sustained unresponsiveness

Access to Document

10.1111/cea.14137

Cite this

Loke, P., Hsiao, K. C., Lozinsky, A. C., Ashley, S. E., Lloyd, M., Pitkin, S., Axelrad, C. J., Jayawardana, K. S., Tey, D., Su, E. L., Robinson, M., Leung, A. S. Y., Dunn Galvin, A., & Tang, M. L. K. (2022). Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement. Clinical and Experimental Allergy, 52(6), 806-811. https://doi.org/10.1111/cea.14137

@article{3d6b01eedb45469f915d1ebcb1a73ba2,

title = "Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement",

keywords = "health-related quality of life, oral immunotherapy, Peanut allergy, probiotic and peanut oral immunotherapy, sustained unresponsiveness",

author = "Paxton Loke and Hsiao, \{Kuang Chih\} and Lozinsky, \{Adriana Chebar\} and Ashley, \{Sarah E.\} and Melanie Lloyd and Sigrid Pitkin and Axelrad, \{Christine Jean\} and Jayawardana, \{Kaushala S.\} and Dean Tey and Su, \{Ee Lyn\} and Marnie Robinson and Leung, \{Agnes S.Y.\} and \{Dunn Galvin\}, Audrey and Tang, \{Mimi L.K.\}",

year = "2022",

month = jun,

doi = "10.1111/cea.14137",

language = "English",

volume = "52",

pages = "806--811",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

Loke, P, Hsiao, KC, Lozinsky, AC, Ashley, SE, Lloyd, M, Pitkin, S, Axelrad, CJ, Jayawardana, KS, Tey, D, Su, EL, Robinson, M, Leung, ASY, Dunn Galvin, A & Tang, MLK 2022, 'Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement', Clinical and Experimental Allergy, vol. 52, no. 6, pp. 806-811. https://doi.org/10.1111/cea.14137

TY - JOUR

T1 - Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement

AU - Loke, Paxton

AU - Hsiao, Kuang Chih

AU - Lozinsky, Adriana Chebar

AU - Ashley, Sarah E.

AU - Lloyd, Melanie

AU - Pitkin, Sigrid

AU - Axelrad, Christine Jean

AU - Jayawardana, Kaushala S.

AU - Tey, Dean

AU - Su, Ee Lyn

AU - Robinson, Marnie

AU - Leung, Agnes S.Y.

AU - Dunn Galvin, Audrey

AU - Tang, Mimi L.K.

PY - 2022/6

Y1 - 2022/6

KW - health-related quality of life

KW - oral immunotherapy

KW - Peanut allergy

KW - probiotic and peanut oral immunotherapy

KW - sustained unresponsiveness

UR - https://www.scopus.com/pages/publications/85129733139

U2 - 10.1111/cea.14137

DO - 10.1111/cea.14137

M3 - Letter

C2 - 35485166

AN - SCOPUS:85129733139

SN - 0954-7894

VL - 52

SP - 806

EP - 811

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 6

ER -

Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement

Keywords

Access to Document

Other files and links

Cite this